Johnson and Johnson ordered to pay $572m in landmark opioid liability case
BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l5319 (Published 29 August 2019) Cite this as: BMJ 2019;366:l5319- Owen Dyer
An Oklahoma judge has ruled that Johnson and Johnson helped to fuel the state’s opioid crisis, in the first case where a US court has found an opioid maker liable in America’s addiction epidemic.
Thad Balkman, Cleveland County district judge, ordered the company to pay Oklahoma $572m (£467m; €516m) to fund treatment programmes, law enforcement, and other costs associated with the epidemic.
“The opioid crisis has ravaged the state of Oklahoma and must be abated immediately,” Balkman said, reading his decision. “As a matter of law, I find that defendants’ actions caused harm.”
The ruling comes as Purdue Pharma, the maker of OxyContin and a company frequently accused of promoting excessive opioid use by physicians, is mulling a global settlement of over 2000 consolidated lawsuits that could see its owners, the Sackler family, relinquish control of the company.
Purdue was originally one of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.